News Article

As cardiovascular disease continues to place mounting pressure on the UK healthcare system, Candesic’s Dr Leonid Shapiro, Managing Partner, and Dr Kristoffer Kenttä, Senior Engagement Manager and Cardiologist, explore what’s driving investor interest in this high-cost, high-impact sector in the August/September edition of LaingBuisson’s HealthcareMarkets.

With direct annual spend on cardiovascular diseases (CVD) approaching £17bn, digital tools are reshaping prevention, monitoring, and long-term management. Improved community-based hypertension care alone could generate £900m in annual savings, while remote monitoring for heart failure could save a further £300m per year by reducing avoidable hospital admissions. Recent NHS trials also show how remote rehab programmes are already improving outcomes for heart patients.

It’s no surprise this whitespace has already attracted more than £7.4bn in investment across Europe and the US, with innovators like Huma and Luscii showing how proactive digital solutions can transform patient outcomes and reduce system costs.